Resumen

MALLA, Ivone et al. Rifaximin for hepatic encephalopathy in children: Case report. Arch. argent. pediatr. [online]. 2011, vol.109, n.6, pp.113-115. ISSN 0325-0075.  http://dx.doi.org/10.5546/aap.2011.e113.

Rifaximin is an antibiotic recently approved for the treatment of hepatic encephalopathy in adults. In children more than 12 year-old, it has been approved for travelers' diarrhea and it is also widely used in infammatory bowel disease. We report, to our knowledge, the frst case of a pediatric patient who received rifaximin for hepatic encephalopathy with good clinical outcome.

Palabras clave : Rifaximin; Hepatic encephalopathy; Pediatrics.

        · resumen en Español     · texto en Español     · Español ( pdf )